Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.
ncRNA name
ANXA2P2
Specific or universal ncRNAs
Specific ncRNAs
Class
Long noncoding RNA
Biomarker
None
Biomarker application
Upstream regulatory factors
Not available
Downstream target
miR-361-3p/SOX9
Cancer name
Cervical Cancer
Cancer site
qRT-PCR,Western blot,Dual-Luciferase assay
Treatment type
Chemotherapy
Drug
Cisplatin
Impact of wild-type ncRNA on chemotherapy resistance
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
Collectively, SOX9, lncRNA ANXA2P2, and miR-361-3p form a regulatory loop, modulating DDP-resistant cervical cancer cell growth and response to DDP treatment
Tissue resource
cisplatin-sensitive and cisplatin-resistant cervical cancer tissues
cervical cancer cell lines Caski
cervical cancer cell lines HeLa
Experiment
None
Institute
Second Xiangya Hospital, Central South University
American Type Culture Collection
Eagle's Minimum Essential Medium
Country
China
United States
United States
Continent
Asia
Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.